Previous Article | Next Article 
Journal of Virology, October 2000, p. 9054-9061, Vol. 74, No. 19
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Novel Class of Thiourea Compounds That Inhibit Herpes Simplex
Virus Type 1 DNA Cleavage and Encapsidation: Resistance Maps to the
UL6 Gene
Marja
van
Zeijl,1,*
Jeanette
Fairhurst,1
Thomas R.
Jones,1
Steven K.
Vernon,2
John
Morin,3
James
LaRocque,3
Boris
Feld,1
Bryan
O'Hara,1,
Jonathan D.
Bloom,4 and
Stephen V.
Johann1
Department of Molecular
Biology/Virology,1 Department of
Automation and Robotics,3 and Chemical
Sciences,4 Wyeth-Ayerst Research, Pearl River,
New York 10965, and Core Biotechnology Group, Wyeth-Ayerst
Research, Radnor, Pennsylvania 190872
Received 22 March 2000/Accepted 7 July 2000
In our search for novel inhibitors of herpes simplex virus type 1 (HSV-1), a new class of thiourea inhibitors was discovered. N-{4-[3-(5-Chloro-2,4-dimethoxyphenyl)-thioureido]-phenyl}-acetamide and its 2-fluoro-benzamide derivative inhibited HSV-1 replication. HSV-2, human cytomegalovirus, and varicella-zoster virus were inhibited
to a lesser extent. The compounds acted late in the replication cycle
by impairing both the cleavage of concatameric viral DNA into progeny
genome length and the packaging of the DNA into capsids, indicative of
a defect in the encapsidation process. To uncover the molecular target
of the inhibition, resistant HSV-1 isolates were generated, and the
mutation responsible for the resistance was mapped using marker
transfer techniques. Each of three independent isolates had point
mutations in the UL6 gene which resulted in independent
single-amino-acid changes. One mutation was located in the N terminus
of the protein (E121D), while two were located close together in the C
terminus (A618V and Q621R). Each of these point mutations was
sufficient to confer drug resistance when introduced into wild-type
virus. The UL6 gene is one of the seven HSV-1 genes known to play a
role in DNA packaging. This novel class of inhibitors has provided a
new tool for dissection of HSV-1 encapsidation mechanisms and has
uncovered a new viable target for the treatment of herpesviral diseases.
*
Corresponding author. Mailing address: Department of
Molecular Biology/Virology, Wyeth-Ayerst Research, N. Middletown Road, Pearl River, NY 10965. Phone: (845) 732-5000. Fax: (845) 732-2480. E-mail: vanzeim{at}war.wyeth.com.

Present address: Progenics Pharmaceuticals, Tarrytown, NY
10591.
Journal of Virology, October 2000, p. 9054-9061, Vol. 74, No. 19
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wang, J. B., McVoy, M. A.
(2008). Mutagenesis of the murine cytomegalovirus M56 terminase gene. J. Gen. Virol.
89: 2864-2868
[Abstract]
[Full Text]
-
Yang, K., Homa, F., Baines, J. D.
(2007). Putative Terminase Subunits of Herpes Simplex Virus 1 Form a Complex in the Cytoplasm and Interact with Portal Protein in the Nucleus. J. Virol.
81: 6419-6433
[Abstract]
[Full Text]
-
Pesola, J. M., Coen, D. M.
(2007). In vivo fitness and virulence of a drug-resistant herpes simplex virus 1 mutant. J. Gen. Virol.
88: 1410-1414
[Abstract]
[Full Text]
-
Pesola, J. M., Zhu, J., Knipe, D. M., Coen, D. M.
(2005). Herpes Simplex Virus 1 Immediate-Early and Early Gene Expression during Reactivation from Latency under Conditions That Prevent Infectious Virus Production. J. Virol.
79: 14516-14525
[Abstract]
[Full Text]
-
Evers, D. L., Komazin, G., Ptak, R. G., Shin, D., Emmer, B. T., Townsend, L. B., Drach, J. C.
(2004). Inhibition of Human Cytomegalovirus Replication by Benzimidazole Nucleosides Involves Three Distinct Mechanisms. Antimicrob. Agents Chemother.
48: 3918-3927
[Abstract]
[Full Text]
-
Jones, T. R., Lee, S.-W., Johann, S. V., Razinkov, V., Visalli, R. J., Feld, B., Bloom, J. D., O'Connell, J.
(2004). Specific Inhibition of Human Cytomegalovirus Glycoprotein B-Mediated Fusion by a Novel Thiourea Small Molecule. J. Virol.
78: 1289-1300
[Abstract]
[Full Text]
-
Komazin, G., Townsend, L. B., Drach, J. C.
(2004). Role of a Mutation in Human Cytomegalovirus Gene UL104 in Resistance to Benzimidazole Ribonucleosides. J. Virol.
78: 710-715
[Abstract]
[Full Text]
-
Newcomb, W. W., Thomsen, D. R., Homa, F. L., Brown, J. C.
(2003). Assembly of the Herpes Simplex Virus Capsid: Identification of Soluble Scaffold-Portal Complexes and Their Role in Formation of Portal-Containing Capsids. J. Virol.
77: 9862-9871
[Abstract]
[Full Text]
-
White, C. A., Stow, N. D., Patel, A. H., Hughes, M., Preston, V. G.
(2003). Herpes Simplex Virus Type 1 Portal Protein UL6 Interacts with the Putative Terminase Subunits UL15 and UL28. J. Virol.
77: 6351-6358
[Abstract]
[Full Text]
-
Visalli, R. J., Fairhurst, J., Srinivas, S., Hu, W., Feld, B., DiGrandi, M., Curran, K., Ross, A., Bloom, J. D., van Zeijl, M., Jones, T. R., O'Connell, J., Cohen, J. I.
(2003). Identification of Small Molecule Compounds That Selectively Inhibit Varicella-Zoster Virus Replication. J. Virol.
77: 2349-2358
[Abstract]
[Full Text]
-
Newcomb, W. W., Brown, J. C.
(2002). Inhibition of Herpes Simplex Virus Replication by WAY-150138: Assembly of Capsids Depleted of the Portal and Terminase Proteins Involved in DNA Encapsidation. J. Virol.
76: 10084-10088
[Abstract]
[Full Text]